Eric Chen

Company: Achelois BioPharma

Job title: Founder & Chief Executive Officer

Bio:

Before starting Achelois, Dr. Chang-Zheng (Eric) Chen was on the faculty at Stanford University School of Medicine. He made pioneering contributions in the fields of microRNA, stem cell biology, cancer, and immunology. He was awarded the Director’s Pioneer Award by the National Institute of Health and Distinguished Young Scholar in Medical Research by the W.M. Keck Foundation. Dr. Chen holds numerous patents and is widely published in many prestigious peer-reviewed journals. He also co-founded Ab-Mart Inc., antibody discovery and therapeutic company based in Shanghai. He completed his postdoctoral training with Professor Harvey Lodish at Whitehead Institute/MIT and received his Ph.D. from Shanghai Institute of Biochemistry at the Chinese Academy of Sciences.

Seminars:

A Novel Approach to Generate Tumor-Targeting T-Cells for Solid Tumors 11:00 am

Leveraging GEMs to identify and enrich neoantigen-specific TILs via engineered APCs Enhancing TIL metabolic fitness using GEMs to boost persistence, trafficking, and function Applying antigen and GEM-based strategies to improve TIL quality and overcome tumor resistanceRead more

day: Conference Day Two R&D Track AM